If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

Google's Gemini 2.0 just rolled out to everyone. The tech giant has several models that compete with trending tech from ...